25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

BioSenic S.A.
Buy, Hold or Sell?

Let's analyze Biosenic together

I guess you are interested in BioSenic S.A.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of BioSenic S.A.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about BioSenic S.A.

I send you an email if I find something interesting about BioSenic S.A..

Quick analysis of Biosenic (30 sec.)










What can you expect buying and holding a share of Biosenic? (30 sec.)

How much money do you get?

How much money do you get?
‚ā¨0.00
When do you have the money?
1 year
How often do you get paid?
40.0%

What is your share worth?

Current worth
‚ā¨-0.09
Expected worth in 1 year
‚ā¨-0.50
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
‚ā¨-0.41
Return On Investment
-3,483.9%

For what price can you sell your share?

Current Price per Share
‚ā¨0.01
Expected price per share
‚ā¨0 - ‚ā¨0.013
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

1. Valuation of Biosenic (5 min.)




Live pricePrice per Share (EOD)

‚ā¨0.01

Intrinsic Value Per Share

‚ā¨-0.28 - ‚ā¨0.55

Total Value Per Share

‚ā¨-0.37 - ‚ā¨0.46

2. Growth of Biosenic (5 min.)




Is Biosenic growing?

Current yearPrevious yearGrowGrow %
How rich?-$24.7m$3.4m-$28.1m-113.8%

How much money is Biosenic making?

Current yearPrevious yearGrowGrow %
Making money-$31.3m-$2.2m-$29.1m-92.9%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Biosenic (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

What can you expect buying and holding a share of Biosenic? (5 min.)

Welcome investor! Biosenic's management wants to use your money to grow the business. In return you get a share of Biosenic.

What can you expect buying and holding a share of Biosenic?

First you should know what it really means to hold a share of Biosenic. And how you can make/lose money.

Speculation

The Price per Share of Biosenic is ‚ā¨0.0118. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biosenic.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biosenic, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ‚ā¨-0.09. Based on the TTM, the Book Value Change Per Share is ‚ā¨-0.10 per quarter. Based on the YOY, the Book Value Change Per Share is ‚ā¨0.04 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ‚ā¨0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biosenic.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ‚ā¨% of Price per Share‚ā¨% of Price per Share‚ā¨% of Price per Share‚ā¨% of Price per Share‚ā¨% of Price per Share
Usd Eps-0.12-1,056.4%-0.12-1,056.4%-0.01-74.9%-0.06-485.6%-0.05-462.5%
Usd Book Value Change Per Share-0.11-948.2%-0.11-948.2%0.04363.0%-0.02-199.7%-0.01-83.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.9%
Usd Total Gains Per Share-0.11-948.2%-0.11-948.2%0.04363.0%-0.02-199.7%-0.01-82.7%
Usd Price Per Share0.07-0.07-0.10-1.54-5.07-
Price to Earnings Ratio-0.53--0.53--11.82--33.52--89.72-
Price-to-Total Gains Ratio-0.60--0.60-2.44-24.39-53.73-
Price to Book Ratio-0.68--0.68-7.72-125.22-199.95-
Price-to-Total Gains Ratio-0.60--0.60-2.44-24.39-53.73-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.01284548
Number of shares77848
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.11-0.02
Usd Total Gains Per Share-0.11-0.02
Gains per Quarter (77848 shares)-8,709.81-1,834.15
Gains per Year (77848 shares)-34,839.22-7,336.62
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-34839-348490-7337-7347
20-69678-696880-14673-14684
30-104518-1045270-22010-22021
40-139357-1393660-29346-29358
50-174196-1742050-36683-36695
60-209035-2090440-44020-44032
70-243875-2438830-51356-51369
80-278714-2787220-58693-58706
90-313553-3135610-66030-66043
100-348392-3484000-73366-73380

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.012.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%4.06.00.040.0%5.07.00.041.7%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%4.00.06.040.0%4.00.08.033.3%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%4.06.00.040.0%5.07.00.041.7%
3rd party ad coffee SUPPORTERis ad-free.

Fundamentals of Biosenic

About BioSenic S.A.

BioSenic S.A., a biotech company, focuses on developing clinical assets. Its technologies include cutting-edge allogeneic cell and gene therapy platform with differentiated bone marrow sourced mesenchymal stromal cells, which can be stored at the point of use in the hospital; and Arsenic TriOxide platform for use in immuno-oncology to treat graft-versus-host disease, systemic lupus erythematosus, and systemic sclerosis. The company's investigational medicinal product is ALLOB, which is in a Phase IIb clinical trial in patients with difficult tibial fractures' and ArsciCor, which is in Phase III in GvHD is being prepared with an oral treatment. BioSenic S.A. is based in Mont-Saint-Guibert, Belgium.

Fundamental data was last updated by Penke on 2024-07-09 13:20:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

1.1. Profitability of BioSenic S.A..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit¬†Biosenic earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare¬†Biosenic to the¬†Biotechnology industry mean.
  • A Net Profit Margin of 0.0%¬†means that¬†€0.00 for each €1¬†in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of BioSenic S.A.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-497.3%+497.3%
5Y-497.3%10Y-3,631.8%+3,134.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--169.1%+169.1%
TTM--210.0%+210.0%
YOY--235.1%+235.1%
5Y-497.3%-391.9%-105.4%
10Y-3,631.8%-505.7%-3,126.1%
1.1.2. Return on Assets

Shows how efficient Biosenic is using its assets to generate profit.

  • Above 5% is considered healthy¬†but always compare¬†Biosenic to the¬†Biotechnology industry mean.
  • -301.1% Return on Assets means that¬†Biosenic generated¬†€-3.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of BioSenic S.A.:

  • The MRQ is -301.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -301.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-301.1%TTM-301.1%0.0%
TTM-301.1%YOY-7.0%-294.1%
TTM-301.1%5Y-93.6%-207.4%
5Y-93.6%10Y-65.9%-27.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-301.1%-11.7%-289.4%
TTM-301.1%-11.9%-289.2%
YOY-7.0%-11.2%+4.2%
5Y-93.6%-13.3%-80.3%
10Y-65.9%-14.7%-51.2%
1.1.3. Return on Equity

Shows how efficient Biosenic is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare¬†Biosenic to the¬†Biotechnology industry mean.
  • 0.0% Return on Equity means Biosenic generated €0.00¬†for each¬†€1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of BioSenic S.A.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-57.9%+57.9%
TTM-5Y-185.6%+185.6%
5Y-185.6%10Y-191.5%+5.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--14.1%+14.1%
TTM--15.2%+15.2%
YOY-57.9%-14.1%-43.8%
5Y-185.6%-18.8%-166.8%
10Y-191.5%-19.3%-172.2%
3rd party ad coffee SUPPORTERis ad-free.

1.2. Operating Efficiency of BioSenic S.A..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Biosenic is operating .

  • Measures how much profit Biosenic makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare¬†Biosenic to the¬†Biotechnology industry mean.
  • An Operating Margin of 0.0%¬†means the company generated €0.00 ¬†for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of BioSenic S.A.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-541.3%+541.3%
5Y-541.3%10Y-3,477.3%+2,936.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--354.6%+354.6%
TTM--224.3%+224.3%
YOY--238.4%+238.4%
5Y-541.3%-396.3%-145.0%
10Y-3,477.3%-510.1%-2,967.2%
1.2.2. Operating Ratio

Measures how efficient Biosenic is keeping operating costs low.

  • Below 1 is considered healthy (always compare to¬†Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are €0.00 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of BioSenic S.A.:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y5.811-5.811
5Y5.81110Y36.719-30.908
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.003-3.003
TTM-3.247-3.247
YOY-3.459-3.459
5Y5.8115.029+0.782
10Y36.7196.568+30.151
3rd party ad coffee SUPPORTERis ad-free.

1.3. Liquidity of BioSenic S.A..

1.3. Liquidity
1.3.1. Current Ratio

Measures if Biosenic is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to¬†Biotechnology industry mean).
  • A Current Ratio of 0.12¬†means the company has €0.12 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of BioSenic S.A.:

  • The MRQ is 0.117. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.117. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.117TTM0.1170.000
TTM0.117YOY0.447-0.330
TTM0.1175Y1.177-1.060
5Y1.17710Y1.626-0.450
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1173.793-3.676
TTM0.1174.052-3.935
YOY0.4474.958-4.511
5Y1.1775.990-4.813
10Y1.6266.333-4.707
1.3.2. Quick Ratio

Measures if Biosenic is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but¬†always compare¬†Biosenic to the¬†Biotechnology industry mean.
  • A Quick Ratio of 0.10¬†means the company can pay off €0.10 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of BioSenic S.A.:

  • The MRQ is 0.099. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.099. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.099TTM0.0990.000
TTM0.099YOY0.408-0.309
TTM0.0995Y1.094-0.994
5Y1.09410Y1.577-0.484
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0993.198-3.099
TTM0.0993.584-3.485
YOY0.4084.867-4.459
5Y1.0945.926-4.832
10Y1.5776.439-4.862
3rd party ad coffee SUPPORTERis ad-free.

1.4. Solvency of BioSenic S.A..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Biosenic assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare¬†Biosenic to Biotechnology industry mean.
  • A Debt to Asset Ratio of 3.38¬†means that Biosenic assets are¬†financed with 337.5% credit (debt) and the remaining percentage (100% - 337.5%)¬†is financed by its owners/shareholders.¬†

Let's take a look of the Debt to Asset Ratio trends of BioSenic S.A.:

  • The MRQ is 3.375. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 3.375. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ3.375TTM3.3750.000
TTM3.375YOY0.893+2.482
TTM3.3755Y1.477+1.898
5Y1.47710Y1.155+0.322
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.3750.328+3.047
TTM3.3750.339+3.036
YOY0.8930.286+0.607
5Y1.4770.368+1.109
10Y1.1550.383+0.772
1.4.2. Debt to Equity Ratio

Measures if Biosenic is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but¬†always compare¬†Biosenic to the¬†Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has €0.00 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of BioSenic S.A.:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY7.431-7.431
TTM-5Y4.767-4.767
5Y4.76710Y4.045+0.722
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.363-0.363
TTM-0.413-0.413
YOY7.4310.368+7.063
5Y4.7670.438+4.329
10Y4.0450.476+3.569
3rd party ad coffee SUPPORTERis ad-free.

2. Market Valuation of BioSenic S.A.

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures¬†how much money you pay¬†for each share for¬†every €1 in earnings Biosenic generates.

  • Above 15 is considered overpriced but¬†always compare¬†Biosenic to the¬†Biotechnology industry mean.
  • A PE ratio of -0.53 means the investor is paying €-0.53¬†for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of BioSenic S.A.:

  • The EOD is -0.103. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.534. Based on the earnings, the company is expensive. -2
  • The TTM is -0.534. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.103MRQ-0.534+0.431
MRQ-0.534TTM-0.5340.000
TTM-0.534YOY-11.821+11.286
TTM-0.5345Y-33.519+32.985
5Y-33.51910Y-89.719+56.200
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.103-2.525+2.422
MRQ-0.534-3.017+2.483
TTM-0.534-2.871+2.337
YOY-11.821-3.568-8.253
5Y-33.519-6.225-27.294
10Y-89.719-6.350-83.369
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of BioSenic S.A.:

  • The EOD is -0.848. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -4.397. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -4.397. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.848MRQ-4.397+3.549
MRQ-4.397TTM-4.3970.000
TTM-4.397YOY-12.598+8.202
TTM-4.3975Y-31.161+26.764
5Y-31.16110Y-90.521+59.359
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.848-3.099+2.251
MRQ-4.397-3.748-0.649
TTM-4.397-3.740-0.657
YOY-12.598-5.029-7.569
5Y-31.161-8.012-23.149
10Y-90.521-8.617-81.904
3rd party ad coffee SUPPORTERis ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Biosenic is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy¬†(always compare to Biotechnology industry mean).
  • A PB ratio of -0.68 means the investor is paying €-0.68¬†for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of BioSenic S.A.:

  • The EOD is -0.131. Based on the equity, the company is expensive. -2
  • The MRQ is -0.677. Based on the equity, the company is expensive. -2
  • The TTM is -0.677. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.131MRQ-0.677+0.547
MRQ-0.677TTM-0.6770.000
TTM-0.677YOY7.723-8.400
TTM-0.6775Y125.221-125.898
5Y125.22110Y199.949-74.729
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.1311.936-2.067
MRQ-0.6772.247-2.924
TTM-0.6772.301-2.978
YOY7.7232.382+5.341
5Y125.2213.662+121.559
10Y199.9494.139+195.810
2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

3. Summary

3.1. Key Performance Indicators

The key performance indicators of BioSenic S.A. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.103-0.1030%0.039-361%-0.022-79%-0.009-91%
Book Value Per Share---0.090-0.0900%0.012-827%-0.017-82%0.008-1245%
Current Ratio--0.1170.1170%0.447-74%1.177-90%1.626-93%
Debt To Asset Ratio--3.3753.3750%0.893+278%1.477+129%1.155+192%
Debt To Equity Ratio----0%7.431-100%4.767-100%4.045-100%
Dividend Per Share----0%-0%-0%0.000-100%
Eps---0.115-0.1150%-0.008-93%-0.053-54%-0.050-56%
Free Cash Flow Per Share---0.014-0.0140%-0.008-45%-0.036+159%-0.041+195%
Free Cash Flow To Equity Per Share---0.007-0.0070%-0.003-50%-0.011+53%-0.003-56%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--0.546--------
Intrinsic Value_10Y_min---0.280--------
Intrinsic Value_1Y_max---0.007--------
Intrinsic Value_1Y_min---0.038--------
Intrinsic Value_3Y_max--0.025--------
Intrinsic Value_3Y_min---0.107--------
Intrinsic Value_5Y_max--0.115--------
Intrinsic Value_5Y_min---0.166--------
Market Cap2965493.306-419%15380355.11015380355.1100%24126047.232-36%355266098.011-96%1171450275.869-99%
Net Profit Margin----0%-0%-4.9730%-36.3180%
Operating Margin----0%-0%-5.4130%-34.7730%
Operating Ratio----0%-0%5.811-100%36.719-100%
Pb Ratio-0.131+81%-0.677-0.6770%7.723-109%125.221-101%199.949-100%
Pe Ratio-0.103+81%-0.534-0.5340%-11.821+2112%-33.519+6172%-89.719+16687%
Price Per Share0.012-419%0.0610.0610%0.096-36%1.414-96%4.661-99%
Price To Free Cash Flow Ratio-0.848+81%-4.397-4.3970%-12.598+187%-31.161+609%-90.521+1959%
Price To Total Gains Ratio-0.115+81%-0.595-0.5950%2.440-124%24.394-102%53.725-101%
Quick Ratio--0.0990.0990%0.408-76%1.094-91%1.577-94%
Return On Assets---3.011-3.0110%-0.070-98%-0.936-69%-0.659-78%
Return On Equity----0%-0.5790%-1.8560%-1.9150%
Total Gains Per Share---0.103-0.1030%0.039-361%-0.022-79%-0.009-91%
Usd Book Value---24716663.000-24716663.0000%3400786.400-827%-4566241.560-82%2159020.380-1245%
Usd Book Value Change Per Share---0.112-0.1120%0.043-361%-0.024-79%-0.010-91%
Usd Book Value Per Share---0.098-0.0980%0.014-827%-0.018-82%0.009-1245%
Usd Dividend Per Share----0%-0%-0%0.000-100%
Usd Eps---0.125-0.1250%-0.009-93%-0.057-54%-0.055-56%
Usd Free Cash Flow---3807922.800-3807922.8000%-2084669.000-45%-9860321.080+159%-11245782.300+195%
Usd Free Cash Flow Per Share---0.015-0.0150%-0.008-45%-0.039+159%-0.045+195%
Usd Free Cash Flow To Equity Per Share---0.008-0.0080%-0.004-50%-0.012+53%-0.003-56%
Usd Market Cap3228236.012-419%16743054.57316743054.5730%26263615.017-36%386742674.295-96%1275240770.311-99%
Usd Price Per Share0.013-419%0.0670.0670%0.105-36%1.539-96%5.074-99%
Usd Profit---31327730.800-31327730.8000%-2221832.600-93%-14401089.400-54%-13714400.520-56%
Usd Revenue----0%-0%435440.000-100%647390.420-100%
Usd Total Gains Per Share---0.112-0.1120%0.043-361%-0.024-79%-0.010-91%
 EOD+2 -6MRQTTM+0 -0YOY+3 -255Y+9 -2110Y+7 -25

3.2. Fundamental Score

Let's check the fundamental score of BioSenic S.A. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.103
Price to Book Ratio (EOD)Between0-1-0.131
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.099
Current Ratio (MRQ)Greater than10.117
Debt to Asset Ratio (MRQ)Less than13.375
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-3.011
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of BioSenic S.A. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.753
Ma 20Greater thanMa 500.016
Ma 50Greater thanMa 1000.018
Ma 100Greater thanMa 2000.020
OpenGreater thanClose0.013
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. All numbers in thousands.

Summary
Total Assets9,559
Total Liabilities32,264
Total Stockholder Equity-22,912
 As reported
Total Liabilities 32,264
Total Stockholder Equity+ -22,912
Total Assets = 9,559

Assets

Total Assets9,559
Total Current Assets1,846
Long-term Assets7,713
Total Current Assets
Cash And Cash Equivalents 117
Net Receivables 1,456
Other Current Assets 273
Total Current Assets  (as reported)1,846
Total Current Assets  (calculated)1,846
+/-0
Long-term Assets
Property Plant Equipment 698
Long-term Assets Other 135
Long-term Assets  (as reported)7,713
Long-term Assets  (calculated)833
+/- 6,880

Liabilities & Shareholders' Equity

Total Current Liabilities15,844
Long-term Liabilities16,420
Total Stockholder Equity-22,912
Total Current Liabilities
Short-term Debt 11,821
Other Current Liabilities 4,023
Total Current Liabilities  (as reported)15,844
Total Current Liabilities  (calculated)15,844
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)16,420
Long-term Liabilities  (calculated)0
+/- 16,420
Total Stockholder Equity
Common Stock6,275
Retained Earnings -34,887
Accumulated Other Comprehensive Income -20
Other Stockholders Equity 5,720
Total Stockholder Equity (as reported)-22,912
Total Stockholder Equity (calculated)-22,912
+/-0
Other
Cash and Short Term Investments 117
Common Stock Shares Outstanding 124,496
Liabilities and Stockholders Equity 9,559
Net Debt 28,044
Net Working Capital -13,998
Short Long Term Debt Total 28,161



Balance Sheet

All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
> Total Assets 
15,053
14,418
12,811
24,202
50,383
38,585
25,173
25,753
22,393
24,835
19,772
29,324
9,559
9,55929,32419,77224,83522,39325,75325,17338,58550,38324,20212,81114,41815,053
   > Total Current Assets 
13,049
11,767
8,087
19,259
41,701
28,471
14,615
15,000
11,733
18,817
14,291
4,626
1,846
1,8464,62614,29118,81711,73315,00014,61528,47141,70119,2598,08711,76713,049
       Cash And Cash Equivalents 
5,559
4,822
2,440
11,576
33,611
20,300
8,411
8,174
8,633
14,648
9,510
1,846
117
1171,8469,51014,6488,6338,1748,41120,30033,61111,5762,4404,8225,559
       Short-term Investments 
203
0
0
0
0
0
0
0
-140
0
1,200
-111
0
0-1111,2000-1400000000203
       Net Receivables 
0
6,834
5,513
7,498
7,912
8,013
5,938
6,724
3,025
3,841
361
2,490
1,456
1,4562,4903613,8413,0256,7245,9388,0137,9127,4985,5136,8340
       Other Current Assets 
67
111
134
186
177
159
265
102
74
328
1,001
290
273
2732901,0013287410226515917718613411167
   > Long-term Assets 
2,004
2,651
4,724
4,942
8,682
10,114
10,558
10,754
10,660
6,019
5,481
24,698
7,713
7,71324,6985,4816,01910,66010,75410,55810,1148,6824,9424,7242,6512,004
       Property Plant Equipment 
1,137
1,277
2,869
2,667
5,793
6,385
6,302
6,203
6,100
226
863
1,419
698
6981,4198632266,1006,2036,3026,3855,7932,6672,8691,2771,137
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
1,802
0
01,80200000000000
       Long Term Investments 
0
0
282
283
282
291
297
326
472
0
0
0
0
000047232629729128228328200
       Intangible Assets 
0
19
60
53
69
56
30
22
28
28
23
17,293
0
017,293232828223056695360190
       Long-term Assets Other 
204
2
462
-1
487
590
1
-1
1
1
97
25
135
135259711-11590487-14622204
> Total Liabilities 
11,241
11,780
12,748
33,687
22,236
23,315
22,790
21,262
20,345
21,510
26,537
26,200
32,264
32,26426,20026,53721,51020,34521,26222,79023,31522,23633,68712,74811,78011,241
   > Total Current Liabilities 
6,400
5,854
6,246
26,359
10,543
10,513
10,598
9,327
9,339
9,790
6,673
10,353
15,844
15,84410,3536,6739,7909,3399,32710,59810,51310,54326,3596,2465,8546,400
       Short-term Debt 
152
192
509
13,116
2,314
1,242
1,251
2,605
2,709
3,077
1,046
5,058
11,821
11,8215,0581,0463,0772,7092,6051,2511,2422,31413,116509192152
       Short Long Term Debt 
0
0
5,561
427
2,280
1,048
1,130
2,499
2,531
3,045
945
4,826
0
04,8269453,0452,5312,4991,1301,0482,2804275,56100
       Accounts payable 
789
1,116
1,136
2,853
1,818
2,327
2,808
3,242
3,069
5,171
4,502
1,990
0
01,9904,5025,1713,0693,2422,8082,3271,8182,8531,1361,116789
       Other Current Liabilities 
5,459
4,546
-1
6
5
4
775
-10
2,760
358
1
103
4,023
4,02310313582,760-10775456-14,5465,459
   > Long-term Liabilities 
4,841
5,926
6,502
7,328
11,693
12,802
12,192
11,935
11,006
11,720
19,864
15,847
16,420
16,42015,84719,86411,72011,00611,93512,19212,80211,6937,3286,5025,9264,841
       Long term Debt Total 
0
0
0
0
10,118
11,167
10,551
10,247
11,006
0
0
0
0
000011,00610,24710,55111,16710,1180000
       Other Liabilities 
0
1,812
1,450
1,501
1,575
1,636
1,641
1,678
0
0
112
0
0
00112001,6781,6411,6361,5751,5011,4501,8120
> Total Stockholder Equity
3,812
2,637
63
-9,485
28,147
15,270
2,383
4,491
2,048
3,325
-6,765
3,526
-22,912
-22,9123,526-6,7653,3252,0484,4912,38315,27028,147-9,485632,6373,812
   Common Stock
6,943
8,417
9,288
10,466
20,708
20,708
14,663
12,532
5,454
8,415
4,924
4,774
6,275
6,2754,7744,9248,4155,45412,53214,66320,70820,70810,4669,2888,4176,943
   Retained Earnings -34,887-5,723-81,488-73,080-61,586-62,136-55,501-48,773-35,752-21,670-15,860-11,794-8,097
   Capital Surplus 
0
0
0
0
42,670
42,670
42,665
53,478
58,026
0
0
0
0
000058,02653,47842,66542,67042,6700000
   Treasury Stock0000000000000
   Other Stockholders Equity 
4,966
6,014
6,635
1,719
42,670
42,670
42,665
53,478
58,026
67,594
69,799
4,475
5,720
5,7204,47569,79967,59458,02653,47842,66542,67042,6701,7196,6356,0144,966



Balance Sheet

All numbers in thousands.




Cash Flow

All numbers in thousands.




Income Statement

All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-243
Gross Profit-243-243
 
Operating Income (+$)
Gross Profit-243
Operating Expense-7,339
Operating Income-7,582-7,582
 
Operating Expense (+$)
Research Development3,931
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense7,3393,931
 
Net Interest Income (+$)
Interest Income0
Interest Expense-5,954
Other Finance Cost-5,954
Net Interest Income0
 
Pretax Income (+$)
Operating Income-7,582
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-29,02813,864
EBIT - interestExpense = -13,536
-28,785
-22,824
Interest Expense5,954
Earnings Before Interest and Taxes (EBIT)-7,582-23,074
Earnings Before Interest and Taxes (EBITDA)-7,339
 
After tax Income (+$)
Income Before Tax-29,028
Tax Provision-0
Net Income From Continuing Ops0-29,028
Net Income-28,778
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses7,582
Total Other Income/Expenses Net-21,4460
 

Technical Analysis of Biosenic
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biosenic. The general trend of Biosenic is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biosenic's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of BioSenic S.A..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 0.012 < 0.013 < 0.013.

The bearish price targets are: .

Tweet this
BioSenic S.A. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging¬†trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of BioSenic S.A.. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

BioSenic S.A. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a¬†lagging momentum¬†indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of BioSenic S.A.. The current macd is -0.00169169.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Biosenic price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Biosenic. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Biosenic price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
BioSenic S.A. Daily Moving Average Convergence/Divergence (MACD) ChartBioSenic S.A. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of BioSenic S.A.. The current adx is 16.76.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Biosenic shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
BioSenic S.A. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows¬†the current trend.
  • Shows¬†potential entry signals.
  • Shows¬†¬†potential exit signals.
  • Can be used to place¬†trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of BioSenic S.A.. The current sar is 0.01860715.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
BioSenic S.A. Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum¬†indicator, meaning the signals are instant.
  • Ranges¬†between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of BioSenic S.A.. The current rsi is 30.75. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
BioSenic S.A. Daily Relative Strength Index (RSI) ChartBioSenic S.A. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading¬†momentum¬†indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges¬†between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of BioSenic S.A.. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Biosenic price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
BioSenic S.A. Daily Stochastic Oscillator ChartBioSenic S.A. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,¬†the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of BioSenic S.A.. The current cci is -124.94180155.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
BioSenic S.A. Daily Commodity Channel Index (CCI) ChartBioSenic S.A. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of BioSenic S.A.. The current cmo is -52.54354749.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
BioSenic S.A. Daily Chande Momentum Oscillator (CMO) ChartBioSenic S.A. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and¬†-100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of BioSenic S.A.. The current willr is -91.66666667.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
BioSenic S.A. Daily Williams %R ChartBioSenic S.A. Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold¬†

Score

Let's take a look at the Bollinger Bands of BioSenic S.A..

BioSenic S.A. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of BioSenic S.A.. The current atr is 0.00167713.

BioSenic S.A. Daily Average True Range (ATR) ChartBioSenic S.A. Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of BioSenic S.A.. The current obv is -49,717,507.

BioSenic S.A. Daily On-Balance Volume (OBV) ChartBioSenic S.A. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of BioSenic S.A.. The current mfi is 22.02.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
BioSenic S.A. Daily Money Flow Index (MFI) ChartBioSenic S.A. Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for BioSenic S.A..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-20MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-02RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-03WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-25MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-05-16MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-05-17SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-05-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-05-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-05-23STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-05-24STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-05-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-31STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-07STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-06-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-18STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-03STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-04BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-05STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-09WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-07-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-17STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

BioSenic S.A. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of BioSenic S.A. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.753
Ma 20Greater thanMa 500.016
Ma 50Greater thanMa 1000.018
Ma 100Greater thanMa 2000.020
OpenGreater thanClose0.013
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Biosenic with someone you think should read this too:
  • Are you bullish or bearish on Biosenic? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biosenic? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about BioSenic S.A.

I send you an email if I find something interesting about BioSenic S.A..


Comments

How you think about this?

Leave a comment

Stay informed about BioSenic S.A..

Receive notifications about BioSenic S.A. in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.